BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Iloprost

A stable analog of EPOPROSTENOL that is a PLATELET AGGREGATION INHIBITOR; VASODILATOR, and has cytoprotective properties.

300+ PubMed studies analyzed · 40 RCTs · Evidence Score: 51

Research Domains

Iloprost has been studied across 17 research domains including ❤️ Cardiovascular, 🫁 Respiratory, 🔬 Inflammation, 🦴 Bone & Joint, ✨ Skin & Hair. The primary research focus is ❤️ Cardiovascular with 34% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Iloprost, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Epoprostenol
4 shared targets
Cloprostenol
3 shared targets
Prostaglandin
4 shared targets
Dinoprost
5 shared targets
Alprostadil
6 shared targets
Oseltamivir
2 shared targets
Nitroarginine
2 shared targets
Tirofiban
2 shared targets
Lamivudine
2 shared targets
Valsartan
2 shared targets
Loading evidence profile...

This evidence profile for Iloprost is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.